Velbert, Germany

Maria Köllnberger

This inventor holds 7 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Köllnberger. Retrieved from https://idiyas.com/inventor/maria-köllnberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 28.6

 

Average Co-Inventor Count = 13.6

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Maria Köllnberger: Innovator in Pharmaceutical Patents

Introduction

Maria Köllnberger is a prominent inventor based in Velbert, Germany. She has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. Her work primarily focuses on developing novel compounds for the treatment and prevention of various bleeding disorders.

Latest Patents

Among her latest patents are the compounds related to (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones. These compounds are designed for use in treating acute and recurrent bleeding in patients, addressing conditions such as menorrhagia, postpartum hemorrhage, and hemorrhagic shock. Another notable patent involves piperidinylpyrazolopyrimidinones, which also target similar bleeding disorders and aim to improve patient outcomes in various medical interventions.

Career Highlights

Maria has worked with renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues, including Johannes Köbberling and Tom Kinzel. These partnerships have further enhanced her innovative work in the field.

Conclusion

Maria Köllnberger's contributions to pharmaceutical patents demonstrate her commitment to advancing medical treatments for bleeding disorders. Her innovative spirit and collaborative efforts continue to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…